{"id":37816,"date":"2026-09-02T07:51:52","date_gmt":"2026-09-02T14:51:52","guid":{"rendered":"https:\/\/getheally.com\/patients\/news\/?p=37816"},"modified":"2026-09-02T07:56:11","modified_gmt":"2026-09-02T14:56:11","slug":"how-many-americans-are-using-weight-loss-drugs-in-2026","status":"publish","type":"post","link":"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026","title":{"rendered":"How many Americans are using weight loss drugs in 2026?"},"content":{"rendered":"\n<p>About <strong>11% of US adults<\/strong> currently take a GLP-1 weight loss medication \u2014 roughly <strong>28 million people<\/strong>. Another 15% say they&#8217;ve tried one at some point. That&#8217;s a number that has nearly quadrupled since 2024, when only 3% of adults reported current use. And by most projections, it&#8217;s still far short of where the market is headed.<\/p>\n\n\n\n<p>These aren&#8217;t estimates or model projections. The 11% figure comes from a Gallup survey of 5,065 US adults conducted June 2026, the most authoritative measure of real-world prevalence available. The numbers are moving fast enough that whatever was true 18 months ago has likely been overtaken.<\/p>\n\n\n\n<h2 id=\"key-takeaways\" class=\"wp-block-heading\">Key takeaways<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>11% of US adults<\/strong> currently take a GLP-1 drug for weight loss (Gallup, June 2026) \u2014 up from 3% in 2024.<\/li>\n\n\n\n<li><strong>15% of US adults<\/strong> have used one at some point \u2014 a nine percentage point jump from 2025.<\/li>\n\n\n\n<li><strong>91% of US adults<\/strong> are now aware of GLP-1 weight loss drugs, up from 80% two years ago.<\/li>\n\n\n\n<li><strong>37% of Americans<\/strong> say a close friend or family member currently uses one.<\/li>\n\n\n\n<li>Only <strong>1 in 10<\/strong> people who clinically qualify are actually taking a GLP-1 drug, per Eli Lilly&#8217;s CEO.<\/li>\n\n\n\n<li><strong>57.4 million<\/strong> privately insured US adults meet the clinical criteria \u2014 but only a fraction have a prescription.<\/li>\n\n\n\n<li>GLP-1 prescriptions for weight loss grew <strong>587%<\/strong> between 2019 and 2024, per FAIR Health data.<\/li>\n\n\n\n<li>The US adult obesity rate has fallen to <strong>36.4%<\/strong> in 2026 \u2014 down from a peak of 39.9% in 2022.<\/li>\n<\/ul>\n\n\n\n<h2 id=\"the-current-number-28-million-americans\" class=\"wp-block-heading\">The current number: 28 million Americans<\/h2>\n\n\n\n<p>The simplest answer to the question is this: approximately 28 million US adults currently take a GLP-1 receptor agonist for weight loss as of mid-2026. That figure scales from the Gallup 11% finding against the US adult population of about 260 million.<\/p>\n\n\n\n<p>It&#8217;s the highest adoption rate ever recorded for a prescription weight loss drug category in US history.<\/p>\n\n\n\n<p>A separate KFF (Kaiser Family Foundation) poll, which counted GLP-1 use across all indications \u2014 weight loss, diabetes, and cardiovascular disease together \u2014 found roughly <strong>1 in 8 US adults<\/strong> currently taking one. That broader figure is consistent with the Gallup weight-loss-specific number once diabetes-only use is added.<\/p>\n\n\n\n<p>The two surveys together paint a clear picture: somewhere between 28 and 35 million Americans currently use a GLP-1 drug for any reason.<\/p>\n\n\n\n<h2 id=\"how-fast-the-numbers-grew\" class=\"wp-block-heading\">How fast the numbers grew<\/h2>\n\n\n\n<p>The growth rate is arguably as striking as the current number. GLP-1 use for weight loss specifically grew <strong>587% between 2019 and 2024<\/strong>, according to a FAIR Health analysis of over 51 billion commercial healthcare claims records.<\/p>\n\n\n\n<p>The pace has continued accelerating:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th><strong>Year<\/strong><\/th><th><strong>US adults currently using GLP-1 for weight loss<\/strong><\/th><\/tr><\/thead><tbody><tr><td>2019<\/td><td>~0.9%<\/td><\/tr><tr><td>2021<\/td><td>~1.5% (Wegovy FDA approved)<\/td><\/tr><tr><td>2022<\/td><td>~2.5%<\/td><\/tr><tr><td>2024<\/td><td>~3\u20135.8%<\/td><\/tr><tr><td>2026 (Gallup, June)<\/td><td><strong>11%<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>That&#8217;s not linear growth. It&#8217;s exponential adoption driven by three overlapping forces: new drug approvals that produce dramatically better results, expanded insurance and government coverage, and the Wegovy pill launching January 2026 and reaching patients who had avoided injectable GLP-1s.<\/p>\n\n\n\n<p>By the end of the decade, JP Morgan projects up to <strong>30 million Americans<\/strong> on GLP-1 medications \u2014 a number the 2026 data suggests may be reached sooner than that timeline implied when it was written.<\/p>\n\n\n\n<h2 id=\"who-is-using-weight-loss-drugs\" class=\"wp-block-heading\">Who is using weight loss drugs<\/h2>\n\n\n\n<p>The profile of the typical GLP-1 user has shifted meaningfully since 2022.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>By age:<\/strong> Adults aged 40\u201359 account for the largest share of GLP-1 weight loss prescriptions. Use among those under 40 is growing fastest. Adults over 65 report lower effectiveness and are less likely to be on GLP-1s for weight loss, though Medicare coverage through the GLP-1 Bridge program launched July 1, 2026 is opening the door.<\/li>\n\n\n\n<li><strong>By gender:<\/strong> Women account for approximately 60\u201365% of GLP-1 weight loss users. The gap is driven by a combination of higher baseline rates of seeking weight management care and the overlap with conditions like <a href=\"https:\/\/getheally.com\/patients\/pcos-treatment\">PCOS<\/a> and <a href=\"https:\/\/getheally.com\/patients\/perimenopause-treatment\">perimenopause<\/a>, where GLP-1 use is increasingly relevant.<\/li>\n\n\n\n<li><strong>By condition:<\/strong> About 70% of GLP-1 users take the drug at least partly for a chronic condition \u2014 type 2 diabetes, cardiovascular disease, or a weight-related comorbidity \u2014 rather than weight loss alone. The pure weight-loss-only segment is the fastest-growing but not yet the majority.<\/li>\n\n\n\n<li><strong>By awareness:<\/strong> 91% of US adults are now aware of GLP-1 drugs. That&#8217;s near-saturation awareness, typically associated with mainstream categories like statins or blood pressure medications \u2014 not emerging drug classes. The barrier is no longer awareness. It&#8217;s access and cost.<\/li>\n<\/ul>\n\n\n\n<h2 id=\"the-enormous-gap-between-who-qualifies-and-who-gets-access\" class=\"wp-block-heading\">The enormous gap between who qualifies and who gets access<\/h2>\n\n\n\n<p>The most striking number in the 2026 landscape isn&#8217;t how many people are using these drugs. It&#8217;s how many are eligible but aren&#8217;t.<\/p>\n\n\n\n<p><strong><em>57.4 million privately insured US adults<\/em><\/strong><em> meet the clinical criteria for a GLP-1 prescription \u2014 a BMI of 30 or higher, or BMI 27+ with a qualifying comorbidity. That&#8217;s 42% of all adults with private health insurance.<\/em><\/p>\n\n\n\n<p>Of those, only a small fraction \u2014 estimated around 3\u201310% \u2014 had a GLP-1 prescription at the time most of these analyses were conducted. Even at 11% current use, the penetration rate against the eligible population is somewhere around 15\u201320%.<\/p>\n\n\n\n<p>Eli Lilly CEO David Ricks put it plainly in April 2026: <strong>fewer than 1 in 10 people who could benefit from a GLP-1 are taking one.<\/strong><\/p>\n\n\n\n<p>The constraint isn&#8217;t demand or awareness. It&#8217;s two things: cost and coverage. Despite improving, insurance coverage for weight-loss GLP-1s remains incomplete. As of mid-2026:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Only 43% of large employers (5,000+ workers) cover GLP-1s for obesity \u2014 up from 28%, but still a minority<\/li>\n\n\n\n<li>27 million people lack any commercial insurance coverage for Wegovy specifically<\/li>\n\n\n\n<li>Medicare only began covering weight-loss GLP-1s on July 1, 2026 through the GLP-1 Bridge program<\/li>\n<\/ul>\n\n\n\n<p>Each coverage expansion produces a wave of new prescriptions. The July 2026 Medicare Bridge is expected to bring millions of previously ineligible patients into the market before the end of 2026.<\/p>\n\n\n\n<h2 id=\"which-drugs-americans-are-actually-taking\" class=\"wp-block-heading\">Which drugs Americans are actually taking<\/h2>\n\n\n\n<p>Tirzepatide \u2014 sold as <a href=\"https:\/\/getheally.com\/patients\/mounjaro\">Mounjaro<\/a> for diabetes and <a href=\"https:\/\/getheally.com\/patients\/zepbound\">Zepbound<\/a> for weight loss \u2014 overtook semaglutide as the most-prescribed GLP-1 molecule in the US by early 2026. By Q1 2026, tirzepatide ran at roughly <strong>4,700 prescriptions per 100,000 adults<\/strong> versus 3,900 for semaglutide.<\/p>\n\n\n\n<p>That comparison reflects total prescriptions across indications. Within the weight loss segment specifically, <a href=\"https:\/\/getheally.com\/patients\/wegovy\">Wegovy<\/a> commands about 65% of new GLP-1 weight-loss prescriptions as of mid-2026.<\/p>\n\n\n\n<p>The Wegovy pill deserves its own note. Launched January 5, 2026, it passed 3 million prescriptions faster than any GLP-1 in history. It&#8217;s attracting a meaningfully different patient \u2014 people who had been aware of and eligible for GLP-1 therapy but unwilling to take weekly injections. Oral GLP-1s are genuinely expanding the user base rather than just shifting it.<\/p>\n\n\n\n<p>For a full picture of brand-level market share, see <a href=\"https:\/\/getheally.com\/patients\/news\/semaglutide-in-2026-how-many-people-use-it-what-brands-lead-and-where-the-market-is-heading\">semaglutide in 2026 usage guide<\/a>.<\/p>\n\n\n\n<h2 id=\"what-this-is-doing-to-obesity-rates\" class=\"wp-block-heading\">What this is doing to obesity rates<\/h2>\n\n\n\n<p>The population-level effect is becoming visible. After peaking at 39.9% in 2022 \u2014 the year after Wegovy&#8217;s FDA approval \u2014 the US adult obesity rate has fallen to <strong>36.4% in 2026<\/strong>, according to Gallup&#8217;s tracking data. That&#8217;s the first sustained multi-year decline in modern tracking history.<\/p>\n\n\n\n<p>The diabetes trend is telling too. Diabetes diagnosis rates, which had risen slowly for 15 years in line with rising obesity, have now plateaued. They haven&#8217;t reversed yet \u2014 diabetes is a lifetime diagnosis \u2014 but the rate of new diagnoses is stabilizing.<\/p>\n\n\n\n<p>Researchers have attributed both trends directly to GLP-1 adoption. The math is plausible: if 28 million people are losing 10\u201320% of their body weight, the downstream effects on obesity-related disease rates would be expected to show up with a 2\u20134 year lag. That lag is roughly what we&#8217;re observing.<\/p>\n\n\n\n<p>This is likely the beginning of the population-level signal, not the peak of it.<\/p>\n\n\n\n<h2 id=\"where-the-numbers-are-heading\" class=\"wp-block-heading\">Where the numbers are heading<\/h2>\n\n\n\n<p>The trajectory depends on three variables: coverage, price, and the drug pipeline.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Coverage<\/strong> is expanding. The Medicare GLP-1 Bridge (July 2026) is the single biggest access event in the drug&#8217;s history. Medicaid coverage is growing state by state. Employer coverage is increasing but still below 50%.<\/li>\n\n\n\n<li><strong>Price<\/strong> is declining for many patients. TrumpRx pricing capped Ozempic, Wegovy, Mounjaro, and Zepbound at $245\/month for qualifying buyers. LillyDirect self-pay vials start at $299\/month. The Wegovy pill starts at $149\/month. Foundayo (orforglipron), the newest oral GLP-1, launched at $149\/month too.<\/li>\n\n\n\n<li><strong>The drug pipeline<\/strong> keeps raising the ceiling. <a href=\"https:\/\/getheally.com\/patients\/news\/retatrutide-in-2026-phase-3-results-fda-timeline-and-what-comes-next\">Retatrutide<\/a> \u2014 which produced 28.3% average weight loss in Phase 3 trials \u2014 has an NDA filing expected in Q4 2026. When drugs that effective become available, adoption accelerates.<\/li>\n<\/ul>\n\n\n\n<p>JP Morgan&#8217;s projection of 30 million Americans on GLP-1s by end of decade was written when only 3\u20134% of adults were taking them. At 11% and rising, that number may be crossed by 2028 rather than 2030.<\/p>\n\n\n\n<h2 id=\"conclusion\" class=\"wp-block-heading\">Conclusion<\/h2>\n\n\n\n<p>The numbers tell a straightforward story: more Americans are using weight loss drugs than ever before, the growth is accelerating rather than plateauing, and the gap between who could benefit and who currently does remains enormous.<\/p>\n\n\n\n<p>11% of US adults on GLP-1s for weight loss is a record high. It&#8217;s also probably a floor. Coverage is expanding, prices are falling, oral options are removing the injection barrier, and a new wave of drugs is coming that will raise the ceiling on what weight loss medication can do.<\/p>\n\n\n\n<p>The more revealing number might be the one Eli Lilly&#8217;s CEO offered: fewer than 1 in 10 people who could benefit are currently taking these drugs. The story of GLP-1 adoption in America is less than halfway written.<\/p>\n\n\n\n<p>If you&#8217;re one of the people who qualifies but hasn&#8217;t yet started, <a href=\"https:\/\/md.getheally.com\/f\/vshop-book_appt?visit_type_first=true&amp;visit_type_ids=3070\">book a free consultation with Heally<\/a> to explore your options with a licensed provider \u2014 same-day telehealth appointments available in 40+ states, prescription delivered to your door.<\/p>\n\n\n\n<h2 id=\"faq\" class=\"wp-block-heading\">FAQ<\/h2>\n\n\n\n<p><strong>How many Americans are taking weight loss drugs in 2026?<\/strong>&nbsp;<\/p>\n\n\n\n<p>About 11% of US adults \u2014 approximately 28 million people \u2014 currently take a GLP-1 weight loss drug, according to a Gallup survey conducted June 2026. Another 15% report having tried one at some point.<\/p>\n\n\n\n<p><strong>What percentage of Americans have used GLP-1 drugs?<\/strong>&nbsp;<\/p>\n\n\n\n<p>15% of US adults have used a GLP-1 medication for weight loss at some point, up nine percentage points from 2025. 11% are currently using one. A broader measure counting all GLP-1 uses (including diabetes) puts current use at about 1 in 8 adults.<\/p>\n\n\n\n<p><strong>How fast is GLP-1 use growing?<\/strong>&nbsp;<\/p>\n\n\n\n<p>Very fast. Prescriptions for GLP-1 weight loss drugs grew 587% between 2019 and 2024. Current use tripled from 3% to 11% of US adults between 2024 and 2026 alone \u2014 in two years.<\/p>\n\n\n\n<p><strong>Who qualifies for weight loss drugs?<\/strong>&nbsp;<\/p>\n\n\n\n<p>Adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition (type 2 diabetes, hypertension, cardiovascular disease, obstructive sleep apnea). 57.4 million privately insured US adults meet these criteria \u2014 about 42% of adults with private insurance.<\/p>\n\n\n\n<p><strong>Why aren&#8217;t more people using weight loss drugs if so many qualify?<\/strong>&nbsp;<\/p>\n\n\n\n<p>Cost and coverage are the main barriers. Despite improving, only 43% of large employers cover GLP-1s for obesity. Many commercial plans still don&#8217;t cover them for weight loss. Medicare only began covering them for weight loss on July 1, 2026. Even those who can access them sometimes find the out-of-pocket cost prohibitive.<\/p>\n\n\n\n<p><strong>Are weight loss drugs actually reducing obesity in the US?<\/strong>&nbsp;<\/p>\n\n\n\n<p>The data suggests yes. US adult obesity rates fell from a peak of 39.9% in 2022 to 36.4% in 2026 \u2014 the first sustained multi-year decline ever tracked. Researchers have attributed this directly to GLP-1 adoption.<\/p>\n\n\n\n<p><strong>How many Americans will use weight loss drugs by 2030?<\/strong>&nbsp;<\/p>\n\n\n\n<p>JP Morgan projected up to 30 million Americans on GLP-1 drugs by end of decade when 3\u20134% were using them. At 11% and rising, that projection may be reached by 2028. The actual number depends on how fast coverage expands and how new drugs like retatrutide accelerate adoption.<\/p>\n\n\n\n<p><strong>Related reading on Heally:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/getheally.com\/patients\/news\/how-weight-loss-actually-works-calories-metabolism-and-hormones\">How weight loss actually works: calories, metabolism, and hormones<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/getheally.com\/patients\/news\/5-glp-1-trends-to-expect-in-2026-expanded-uses-oral-options-and-more\">5 GLP-1 trends to expect in 2026: expanded uses, oral options, and more<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/getheally.com\/patients\/news\/is-ozempic-becoming-yesterdays-weight-loss-drug\">Is Ozempic becoming yesterday&#8217;s weight loss drug?<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/getheally.com\/patients\/news\/tirzepatide-vs-semaglutide-dosage-for-weight-loss\">Tirzepatide vs semaglutide: key differences and weight loss results<\/a><\/li>\n<\/ul>\n\n\n\n<h2 id=\"sources\" class=\"wp-block-heading\">Sources<\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Gallup \u2014 <a href=\"https:\/\/news.gallup.com\/poll\/712157\/glp-usage-reaches-new-high.aspx\">In US, GLP-1 usage reaches new high (July 2026)<\/a><\/li>\n\n\n\n<li>KFF \u2014 <a href=\"https:\/\/www.kff.org\/health-costs\/poll-finding\/kff-health-tracking-poll\/\">1 in 8 adults currently taking a GLP-1 drug for weight loss, diabetes, or another condition<\/a><\/li>\n\n\n\n<li>FAIR Health \u2014 <a href=\"https:\/\/www.fairhealth.org\/article\/fair-health-releases-report-on-glp-1-agonists\">Use of GLP-1 drugs to treat overweight or obesity increased 587% from 2019 to 2024<\/a><\/li>\n\n\n\n<li>Pabau \u2014 <a href=\"https:\/\/pabau.com\/blog\/glp-1-statistics\/\">65 GLP-1 statistics for 2026 (every figure sourced)<\/a><\/li>\n\n\n\n<li>GoalBMI \/ Forbes Health \u2014 <a href=\"https:\/\/wellness.goalbmi.com\/glp-1-statistics-2026\/\">GLP-1 weight loss statistics 2026: semaglutide and tirzepatide data<\/a><\/li>\n\n\n\n<li>Peterson-KFF Health System Tracker \u2014 <a href=\"https:\/\/www.healthsystemtracker.org\/\">Perspectives from employers on covering GLP-1 agonists for weight loss (2026)<\/a><\/li>\n\n\n\n<li>JP Morgan \u2014 <a href=\"https:\/\/www.jpmorgan.com\/insights\/global-research\/healthcare\/obesity-drugs\">How demand for and supply of weight loss drugs is playing out in 2026<\/a><\/li>\n\n\n\n<li>WHO \u2014 <a href=\"https:\/\/www.who.int\/news\/item\/who-guideline-glp1-obesity\">WHO issues global guideline on the use of GLP-1 medicines in treating obesity (2026)<\/a><\/li>\n<\/ol>\n\n\n\n<p><em>Data disclaimer: Statistics in this article reflect surveys and market data available as of July 2026. GLP-1 adoption is growing rapidly \u2014 check primary sources for the most current figures.<\/em><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"About 11% of US adults currently take a GLP-1 weight loss medication \u2014 roughly 28 million people. Another&hellip;\n","protected":false},"author":7,"featured_media":36638,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1794],"tags":[],"class_list":{"0":"post-37816","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-weight-loss"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>How many Americans use weight loss drugs in 2026? - Heally<\/title>\n<meta name=\"description\" content=\"About 28 million Americans use GLP-1 weight loss drugs in 2026. Explore the latest data on adoption, popular medications, access, costs, and future trends\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How many Americans use weight loss drugs in 2026? - Heally\" \/>\n<meta property=\"og:description\" content=\"About 28 million Americans use GLP-1 weight loss drugs in 2026. Explore the latest data on adoption, popular medications, access, costs, and future trends\" \/>\n<meta property=\"og:url\" content=\"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026\" \/>\n<meta property=\"og:site_name\" content=\"Heally\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/getheally.com\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-02T14:51:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-02T14:56:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2025\/12\/12-hidden-reasons-youre-not-losing-weight-and-how-to-fix-them.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Heally\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Heally\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"10 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026#article\",\"isPartOf\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026\"},\"author\":{\"name\":\"Heally\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/af10deadfddea19cb3f5e0f3919632ea\"},\"headline\":\"How many Americans are using weight loss drugs in 2026?\",\"datePublished\":\"2026-09-02T14:51:52+00:00\",\"dateModified\":\"2026-09-02T14:56:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026\"},\"wordCount\":2007,\"publisher\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026#primaryimage\"},\"thumbnailUrl\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2025\/12\/12-hidden-reasons-youre-not-losing-weight-and-how-to-fix-them.jpg\",\"articleSection\":[\"Weight Loss\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026\",\"url\":\"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026\",\"name\":\"How many Americans use weight loss drugs in 2026? - Heally\",\"isPartOf\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026#primaryimage\"},\"image\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026#primaryimage\"},\"thumbnailUrl\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2025\/12\/12-hidden-reasons-youre-not-losing-weight-and-how-to-fix-them.jpg\",\"datePublished\":\"2026-09-02T14:51:52+00:00\",\"dateModified\":\"2026-09-02T14:56:11+00:00\",\"description\":\"About 28 million Americans use GLP-1 weight loss drugs in 2026. Explore the latest data on adoption, popular medications, access, costs, and future trends\",\"breadcrumb\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026#primaryimage\",\"url\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2025\/12\/12-hidden-reasons-youre-not-losing-weight-and-how-to-fix-them.jpg\",\"contentUrl\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2025\/12\/12-hidden-reasons-youre-not-losing-weight-and-how-to-fix-them.jpg\",\"width\":1000,\"height\":667,\"caption\":\"Woman preparing a healthy salad in a home kitchen, illustrating mindful eating, nutrition tracking, and strategies to overcome a weight loss plateau.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/getheally.com\/patients\/news\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How many Americans are using weight loss drugs in 2026?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#website\",\"url\":\"https:\/\/getheally.com\/patients\/news\/\",\"name\":\"Heally\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/getheally.com\/patients\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#organization\",\"name\":\"Heally\",\"url\":\"https:\/\/getheally.com\/patients\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/wpcdn.getheally.com\/patients\/wp-content\/uploads\/2019\/05\/12231047\/heallybl.png\",\"contentUrl\":\"https:\/\/wpcdn.getheally.com\/patients\/wp-content\/uploads\/2019\/05\/12231047\/heallybl.png\",\"width\":152,\"height\":52,\"caption\":\"Heally\"},\"image\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/getheally.com\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/af10deadfddea19cb3f5e0f3919632ea\",\"name\":\"Heally\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"How many Americans use weight loss drugs in 2026? - Heally","description":"About 28 million Americans use GLP-1 weight loss drugs in 2026. Explore the latest data on adoption, popular medications, access, costs, and future trends","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026","og_locale":"en_US","og_type":"article","og_title":"How many Americans use weight loss drugs in 2026? - Heally","og_description":"About 28 million Americans use GLP-1 weight loss drugs in 2026. Explore the latest data on adoption, popular medications, access, costs, and future trends","og_url":"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026","og_site_name":"Heally","article_publisher":"https:\/\/getheally.com","article_published_time":"2026-09-02T14:51:52+00:00","article_modified_time":"2026-09-02T14:56:11+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2025\/12\/12-hidden-reasons-youre-not-losing-weight-and-how-to-fix-them.jpg","type":"image\/jpeg"}],"author":"Heally","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Heally","Est. reading time":"10 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026#article","isPartOf":{"@id":"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026"},"author":{"name":"Heally","@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/af10deadfddea19cb3f5e0f3919632ea"},"headline":"How many Americans are using weight loss drugs in 2026?","datePublished":"2026-09-02T14:51:52+00:00","dateModified":"2026-09-02T14:56:11+00:00","mainEntityOfPage":{"@id":"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026"},"wordCount":2007,"publisher":{"@id":"https:\/\/getheally.com\/patients\/news\/#organization"},"image":{"@id":"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026#primaryimage"},"thumbnailUrl":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2025\/12\/12-hidden-reasons-youre-not-losing-weight-and-how-to-fix-them.jpg","articleSection":["Weight Loss"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026","url":"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026","name":"How many Americans use weight loss drugs in 2026? - Heally","isPartOf":{"@id":"https:\/\/getheally.com\/patients\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026#primaryimage"},"image":{"@id":"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026#primaryimage"},"thumbnailUrl":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2025\/12\/12-hidden-reasons-youre-not-losing-weight-and-how-to-fix-them.jpg","datePublished":"2026-09-02T14:51:52+00:00","dateModified":"2026-09-02T14:56:11+00:00","description":"About 28 million Americans use GLP-1 weight loss drugs in 2026. Explore the latest data on adoption, popular medications, access, costs, and future trends","breadcrumb":{"@id":"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026#primaryimage","url":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2025\/12\/12-hidden-reasons-youre-not-losing-weight-and-how-to-fix-them.jpg","contentUrl":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2025\/12\/12-hidden-reasons-youre-not-losing-weight-and-how-to-fix-them.jpg","width":1000,"height":667,"caption":"Woman preparing a healthy salad in a home kitchen, illustrating mindful eating, nutrition tracking, and strategies to overcome a weight loss plateau."},{"@type":"BreadcrumbList","@id":"https:\/\/getheally.com\/patients\/news\/how-many-americans-are-using-weight-loss-drugs-in-2026#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/getheally.com\/patients\/news"},{"@type":"ListItem","position":2,"name":"How many Americans are using weight loss drugs in 2026?"}]},{"@type":"WebSite","@id":"https:\/\/getheally.com\/patients\/news\/#website","url":"https:\/\/getheally.com\/patients\/news\/","name":"Heally","description":"","publisher":{"@id":"https:\/\/getheally.com\/patients\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/getheally.com\/patients\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/getheally.com\/patients\/news\/#organization","name":"Heally","url":"https:\/\/getheally.com\/patients\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/","url":"https:\/\/wpcdn.getheally.com\/patients\/wp-content\/uploads\/2019\/05\/12231047\/heallybl.png","contentUrl":"https:\/\/wpcdn.getheally.com\/patients\/wp-content\/uploads\/2019\/05\/12231047\/heallybl.png","width":152,"height":52,"caption":"Heally"},"image":{"@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/getheally.com"]},{"@type":"Person","@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/af10deadfddea19cb3f5e0f3919632ea","name":"Heally"}]}},"_links":{"self":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts\/37816","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/comments?post=37816"}],"version-history":[{"count":2,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts\/37816\/revisions"}],"predecessor-version":[{"id":37818,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts\/37816\/revisions\/37818"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/media\/36638"}],"wp:attachment":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/media?parent=37816"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/categories?post=37816"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/tags?post=37816"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}